{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:54:38Z","timestamp":1793314478351,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004318","name":"Microsoft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.yexmp.2025.104995","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T19:22:46Z","timestamp":1757013766000},"page":"104995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Therapeutic strategies in cystinosis: A focus on cysteamine and beyond"],"prefix":"10.1016","volume":"144","author":[{"given":"Angelo","family":"Santoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri Vincenzo","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2025.104995_bb0005","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/pgmj.2005.044156","article-title":"Cystine calculi: challenging group of stones","volume":"82","author":"Ahmed","year":"2006","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.yexmp.2025.104995_bb0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/13816810903200953","article-title":"Characterization of CTNS mutations in Arab patients with cystinosis","volume":"30","author":"Aldahmesh","year":"2009","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.yexmp.2025.104995_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1203\/00006450-200001000-00007","article-title":"Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations","volume":"47","author":"Anikster","year":"2000","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.yexmp.2025.104995_bb0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ndt\/gfu329","article-title":"Cysteamine (Cystagon\u00ae) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults","volume":"30","author":"Ariceta","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexmp.2025.104995_bb0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00467-017-3856-4","article-title":"Effects of long-term cysteamine treatment in patients with cystinosis","volume":"34","author":"Ariceta","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0030","first-page":"332","article-title":"Cystinosis: a review","volume":"10","author":"Avani","year":"2021","journal-title":"World J. Pharm. Res"},{"key":"10.1016\/j.yexmp.2025.104995_bb0035","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1071\/AN15339","article-title":"Cysteamine: a human health dietary additive with potential to improve livestock growth rate and efficiency","volume":"56","author":"Barnett","year":"2016","journal-title":"Anim. Prod. Sci."},{"key":"10.1016\/j.yexmp.2025.104995_bb0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fped.2018.00058","article-title":"Nephropathic cystinosis: symptoms, treatment, and perspectives of a systemic disease","volume":"6","author":"B\u00e4umner","year":"2018","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.yexmp.2025.104995_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154805","article-title":"Carboxyl-terminal SSLKG motif of the human cystinosin-LKG plays an important role in plasma membrane sorting","volume":"11","author":"Bellomo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2025.104995_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.739","article-title":"A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: pharmacokinetics and safety in healthy male volunteers","volume":"9","author":"Berends","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.yexmp.2025.104995_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/IJNRD.S37603","article-title":"Improving the prognosis of nephropathic cystinosis","author":"Besouw","year":"2014","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"10.1016\/j.yexmp.2025.104995_bb0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.drudis.2013.02.003","article-title":"Cysteamine: an old drug with new potential","volume":"18","author":"Besouw","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.yexmp.2025.104995_bb0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40123-018-0146-6","article-title":"Latest clinical approaches in the ocular management of cystinosis: a review of current practice and opinion from the ophthalmology Cystinosis forum","volume":"7","author":"Biswas","year":"2018","journal-title":"Ophthalmol Therapy"},{"key":"10.1016\/j.yexmp.2025.104995_bb0070","doi-asserted-by":"crossref","first-page":"20961","DOI":"10.1038\/s41598-023-47085-w","article-title":"Evaluation of the efficacy of cystinosin supplementation through CTNS mRNA delivery in experimental models for cystinosis","volume":"13","author":"Bondue","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2025.104995_bb0075","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00467-018-4094-0","article-title":"The aminoglycoside geneticin permits translational readthrough of the CTNS W138X nonsense mutation in fibroblasts from patients with nephropathic cystinosis","volume":"34","author":"Brasell","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ki.2011.277","article-title":"Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults","volume":"81","author":"Brodin-Sartorius","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexmp.2025.104995_bb0085","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.3390\/cells10123273","article-title":"Hematopoietic stem cell gene therapy for cystinosis: from bench-to-bedside","volume":"10","author":"Cherqui","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.yexmp.2025.104995_bb0090","series-title":"Phase 1\/2 Clinical Trial of Autologous Hematopoietic Stem and Progenitor Cell Gene Therapy for Cystinosis","first-page":"100","author":"Cherqui","year":"2023"},{"key":"10.1016\/j.yexmp.2025.104995_bb0095","doi-asserted-by":"crossref","first-page":"13314","DOI":"10.1074\/jbc.M010562200","article-title":"The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif","volume":"276","author":"Cherqui","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexmp.2025.104995_bb0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/cells11010006","article-title":"In vitro and in vivo models to study nephropathic cystinosis","volume":"11","author":"Cheung","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.yexmp.2025.104995_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-015-0307-9","article-title":"Excellent long-term outcome of renal transplantation in cystinosis patients","volume":"10","author":"Cohen","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexmp.2025.104995_bb0110","series-title":"Genetic Syndromes: A Comprehensive Reference Guide","first-page":"1","article-title":"Nephropathic cystinosis","author":"Cooray","year":"2023"},{"key":"10.1016\/j.yexmp.2025.104995_bb0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000495270","article-title":"Molecular basis of cystinosis: geographic distribution, functional consequences of mutations in the CTNS gene, and potential for repair","volume":"141","author":"David","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.yexmp.2025.104995_bb0120","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1681\/ASN.2019090956","article-title":"Cell-based phenotypic drug screening identifies luteolin as candidate therapeutic for nephropathic cystinosis","volume":"31","author":"De Leo","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s44162-024-00041-2","article-title":"Cystinosis\u2014a review of disease pathogenesis, management, and future treatment options","volume":"3","author":"Devitt","year":"2024","journal-title":"J. Rare Dis."},{"key":"10.1016\/j.yexmp.2025.104995_bb0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/end.2005.19.429","article-title":"Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria","volume":"19","author":"Dolin","year":"2005","journal-title":"J. Endourol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0135","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jtos.2023.06.002","article-title":"The gene therapy for corneal pathology with novel nonsense cystinosis mouse lines created by CRISPR gene editing","volume":"29","author":"Dong","year":"2023","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.yexmp.2025.104995_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-016-0426-y","article-title":"Cystinosis: a review","volume":"11","author":"Elmonem","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexmp.2025.104995_bb0145","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12098-015-2014-x","article-title":"Lysosomal storage disorders in Egyptian children","volume":"83","author":"Elmonem","year":"2016","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.yexmp.2025.104995_bb0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","article-title":"Gene therapy using haematopoietic stem and progenitor cells","volume":"22","author":"Ferrari","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yexmp.2025.104995_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41467-017-02536-7","article-title":"Impaired autophagy bridges lysosomal storage disease and epithelial dysfunction in the kidney","volume":"9","author":"Festa","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexmp.2025.104995_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.envadv.2023.100408","article-title":"MSC beneficial effects and limitations, and MSC-derived extracellular vesicles as a new cell-free therapy for tissue regeneration in irradiated condition","volume":"13","author":"Flamant","year":"2023","journal-title":"Environ. Adv."},{"key":"10.1016\/j.yexmp.2025.104995_bb0165","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10792-018-0954-7","article-title":"Ocular changes in nephropathic cystinosis: the course of the gold-dust","volume":"39","author":"Flockerzi","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0170","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1681\/ASN.2019111172","article-title":"Nephropathic cystinosis: a distinct form of CKD\u2013mineral and bone disorder that provides novel insights into the regulation of FGF23","volume":"31","author":"Florenzano","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1086\/302509","article-title":"Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay","volume":"65","author":"Forestier","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yexmp.2025.104995_bb0180","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1007\/s00431-003-1349-x","article-title":"Early oral cysteamine therapy for nephropathic cystinosis","volume":"162","author":"Gahl","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.yexmp.2025.104995_bb0185","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/bj2280545","article-title":"Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange","volume":"228","author":"Gahl","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexmp.2025.104995_bb0190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMra020552","article-title":"Cystinosis","volume":"347","author":"Gahl","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2025.104995_bb0195","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/0003-4819-147-4-200708210-00006","article-title":"Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy","volume":"147","author":"Gahl","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.yexmp.2025.104995_bb0200","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00467-020-04722-0","article-title":"Adherence to cysteamine in nephropathic cystinosis: a unique electronic monitoring experience for a better understanding. A prospective cohort study: CrYSTobs","volume":"36","author":"Gaillard","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0205","doi-asserted-by":"crossref","first-page":"F1155","DOI":"10.1152\/ajprenal.00591.2014","article-title":"The swan-neck lesion: proximal tubular adaptation to oxidative stress in nephropathic cystinosis","volume":"308","author":"Galarreta","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1601409","article-title":"Emerging therapeutic strategies for cystinosis","volume":"13","author":"Goodyer","year":"2025","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.yexmp.2025.104995_bb0215","article-title":"The targeted anti-oxidant MitoQ causes mitochondrial swelling and depolarization in kidney tissue","volume":"6","author":"Gottwald","year":"2018","journal-title":"Phys. Rep."},{"key":"10.1016\/j.yexmp.2025.104995_bb0220","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/hmg\/ddz023","article-title":"Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease","volume":"28","author":"Guha","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexmp.2025.104995_bb0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/mt.2012.214","article-title":"Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis","volume":"21","author":"Harrison","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexmp.2025.104995_bb0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.stem.2020.10.014","article-title":"CRISPR-Cas tools and their application in genetic engineering of human stem cells and organoids","volume":"27","author":"Hendriks","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexmp.2025.104995_bb0235","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jimd.12134","article-title":"Management of bone disease in cystinosis: statement from an international conference","volume":"42","author":"Hohenfellner","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.yexmp.2025.104995_bb0240","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1681\/ASN.2019070712","article-title":"Use of human induced pluripotent stem cells and kidney organoids to develop a cysteamine\/mTOR inhibition combination therapy for cystinosis","volume":"31","author":"Hollywood","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0245","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/ph17050625","article-title":"Research progress of drug delivery systems targeting the kidneys","volume":"17","author":"Huang","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.yexmp.2025.104995_bb0250","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/apa.12807","article-title":"Epidemiology of lysosomal storage diseases in Sweden","volume":"103","author":"Hult","year":"2014","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.yexmp.2025.104995_bb0255","series-title":"Stem Cell Microvesicles Transfer Cystinosin to Human Cystinotic Cells and Reduce Cystine Accumulation In Vitro","author":"Iglesias","year":"2012"},{"key":"10.1016\/j.yexmp.2025.104995_bb0260","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3476(55)80126-6","article-title":"Cystinosis","volume":"47","author":"Israels","year":"1955","journal-title":"J. Pediatr."},{"key":"10.1016\/j.yexmp.2025.104995_bb0265","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/08820139.2020.1712416","article-title":"Mesenchymal stem cell-derived extracellular vesicles: a novel cell-free therapy","volume":"49","author":"Jafarinia","year":"2020","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.yexmp.2025.104995_bb0270","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.molmed.2021.04.004","article-title":"Molecular mechanisms and treatment options of nephropathic cystinosis","volume":"27","author":"Jamalpoor","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.yexmp.2025.104995_bb0275","doi-asserted-by":"crossref","first-page":"E3434","DOI":"10.1073\/pnas.1211198109","article-title":"Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy","volume":"109","author":"J\u00e9z\u00e9gou","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yexmp.2025.104995_bb0280","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00467-023-06211-6","article-title":"Gastrointestinal challenges in nephropathic cystinosis: clinical perspectives","volume":"39","author":"Joseph","year":"2024","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00467-003-1077-5","article-title":"New aspects of the pathogenesis of cystinosis","volume":"18","author":"Kalatzis","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0290","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1093\/emboj\/20.21.5940","article-title":"Cystinosin, the protein defective in cystinosis, is a H+-driven lysosomal cystine transporter","volume":"20","author":"Kalatzis","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.yexmp.2025.104995_bb0295","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00467-020-04487-6","article-title":"Adult complications of nephropathic cystinosis: a systematic review","volume":"36","author":"Kasimer","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0300","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajo.2020.07.052","article-title":"Efficacy and safety of topical cysteamine in corneal cystinosis: a systematic review and meta-analysis","volume":"223","author":"Kaur","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0305","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.kint.2024.07.034","article-title":"Targeted gene therapy for rare genetic kidney diseases","volume":"106","author":"Khare","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexmp.2025.104995_bb0310","first-page":"15","article-title":"Enteric-coated cysteamine bitartrate in cystinosis patients","volume":"1851","author":"Klank","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.yexmp.2025.104995_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-019-0439-2","article-title":"Lysosomal dysfunction in proteinopathic neurodegenerative disorders: possible therapeutic roles of cAMP and zinc","volume":"12","author":"Koh","year":"2019","journal-title":"Mol. Brain"},{"key":"10.1016\/j.yexmp.2025.104995_bb0320","first-page":"115","article-title":"Long-term study of tiopronin in patients with cystinuria","volume":"49","author":"Koide","year":"2003","journal-title":"Hinyokika Kiyo. Acta Urol. Jpn."},{"key":"10.1016\/j.yexmp.2025.104995_bb0325","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5603\/OJ.2021.0034","article-title":"Diagnostics and treatment of ocular complications in infantile nephropathic cystinosis","volume":"6","author":"Kowalczyk","year":"2021","journal-title":"Ophthalmol. J."},{"key":"10.1016\/j.yexmp.2025.104995_bb0330","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ymgme.2013.12.298","article-title":"A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study","volume":"111","author":"Labb\u00e9","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.yexmp.2025.104995_bb0335","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jpeds.2016.12.052","article-title":"Bone complications of cystinosis","volume":"183","author":"Langman","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.yexmp.2025.104995_bb0340","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2215\/CJN.12321211","article-title":"A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety","volume":"7","author":"Langman","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0345","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature25022","article-title":"From haematopoietic stem cells to complex differentiation landscapes","volume":"553","author":"Laurenti","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2025.104995_bb0350","first-page":"81","article-title":"The various renal manifestations of the nephropathic form of cystinosis","volume":"4","author":"Lemire","year":"1984","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0355","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jpeds.2016.12.049","article-title":"Endocrine complications of cystinosis","volume":"183","author":"Levtchenko","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.yexmp.2025.104995_bb0360","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1373\/clinchem.2004.031872","article-title":"Comparison of cystine determination in mixed leukocytes vs polymorphonuclear leukocytes for diagnosis of cystinosis and monitoring of cysteamine therapy","volume":"50","author":"Levtchenko","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.yexmp.2025.104995_bb0365","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1167\/iovs.15-16499","article-title":"Photophobia and corneal crystal density in nephropathic cystinosis: an in vivo confocal microscopy and anterior-segment optical coherence tomography study","volume":"56","author":"Liang","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.yexmp.2025.104995_bb0370","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/bjophthalmol-2020-316450","article-title":"Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride","volume":"105","author":"Liang","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0375","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.3390\/jcm11133856","article-title":"Across the myeloablative spectrum: hematopoietic cell transplant conditioning regimens for pediatric patients with sickle cell disease","volume":"11","author":"Limerick","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.yexmp.2025.104995_bb0380","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40267-017-0398-6","article-title":"Cystadrops\u00ae(cysteamine hydrochloride 0.55% viscous eye-drops solution) in treating corneal cystine crystal deposits in patients with cystinosis: a profile of its use","volume":"33","author":"Lyseng-Williamson","year":"2017","journal-title":"Drugs Ther. Perspect."},{"key":"10.1016\/j.yexmp.2025.104995_bb0385","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2147\/OPTH.S133516","article-title":"Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review","author":"Makuloluwa","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0390","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF01805472","article-title":"Cystinosis in the Federal Republic of Germany. Coordination and analysis of the data","volume":"8","author":"Manz","year":"1985","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.yexmp.2025.104995_bb0395","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.ejhg.5200993","article-title":"Mutational spectrum of the CTNS gene in Italy","volume":"11","author":"Mason","year":"2003","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.yexmp.2025.104995_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-015-0262-5","article-title":"Pressure for drug development in lysosomal storage disorders\u2013a quantitative analysis thirty years beyond the US orphan drug act","volume":"10","author":"Mechler","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexmp.2025.104995_bb0405","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nefroe.2016.04.006","article-title":"Case reports and misdiagnosis of renal tubular acidosis","volume":"36","author":"Medeiros","year":"2016","journal-title":"Nefrolog\u00eda (English Edition)"},{"key":"10.1016\/j.yexmp.2025.104995_bb0410","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1080\/03007995.2017.1354288","article-title":"A systematic literature review of cysteamine bitartrate in the treatment of nephropathic cystinosis","volume":"33","author":"Medic","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.yexmp.2025.104995_bb0415","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"Jama"},{"key":"10.1016\/j.yexmp.2025.104995_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2022.0037","article-title":"Tiopronin-induced membranous nephropathy in a patient with refractory familial cystinuria","volume":"83","author":"Micallef","year":"2022","journal-title":"Br. J. Hosp. Med."},{"key":"10.1016\/j.yexmp.2025.104995_bb0425","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.transci.2014.10.016","article-title":"Hematopoietic stem cells: an overview","volume":"51","author":"Mosaad","year":"2014","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.yexmp.2025.104995_bb0430","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/stem.1835","article-title":"Lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubes","volume":"33","author":"Naphade","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.yexmp.2025.104995_bb0435","doi-asserted-by":"crossref","first-page":"158","DOI":"10.15252\/emmm.201404223","article-title":"Impairment of chaperone-mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis","volume":"7","author":"Napolitano","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.yexmp.2025.104995_bb0440","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.yexmp.2025.104995_bb0445","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00467-007-0650-8","article-title":"Nephropathic cystinosis: late complications of a multisystemic disease","volume":"23","author":"Nesterova","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0450","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00467-012-2242-5","article-title":"Cystinosis: the evolution of a treatable disease","volume":"28","author":"Nesterova","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0455","doi-asserted-by":"crossref","first-page":"32063","DOI":"10.1039\/D4RA04469J","article-title":"Cystine crystal nucleation and decay in the context of cystinuria pathogenesis and treatment","volume":"14","author":"Noble","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.yexmp.2025.104995_bb0460","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00467-014-2980-7","article-title":"Common mutation causes cystinosis in the majority of black south African patients","volume":"30","author":"Owen","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0465","first-page":"244","article-title":"Difficulties in the diagnosis and Management of Nephropathic Cystinosis Nefropatik Sistinozis Olgular\u0131nda Tan\u0131 ve Tedavide Kar\u015f\u0131la\u015f\u0131lan","volume":"10","author":"\u00d6zl\u00fc","year":"2016","journal-title":"Turk. J. Pediatr. Dis."},{"key":"10.1016\/j.yexmp.2025.104995_bb0470","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.3390\/ijms21093369","article-title":"Autophagy in neurodegenerative diseases: a hunter for aggregates","volume":"21","author":"Park","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2025.104995_bb0475","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/stem.2575","article-title":"Concise review: MSC-derived exosomes for cell-free therapy","volume":"35","author":"Phinney","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.yexmp.2025.104995_bb0480","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"science"},{"key":"10.1016\/j.yexmp.2025.104995_bb0485","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexmp.2025.104995_bb0490","series-title":"Avery's Diseases of the Newborn","first-page":"1301","article-title":"Glomerulonephropathies and disorders of tubular function","author":"Richardson","year":"2018"},{"key":"10.1016\/j.yexmp.2025.104995_bb0495","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1191968","article-title":"Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design","volume":"330","author":"Rimer","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.yexmp.2025.104995_bb0500","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00467-018-3974-7","article-title":"Potential use of stem cells as a therapy for cystinosis","volume":"34","author":"Rocca","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0505","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.1167\/iovs.15-17107","article-title":"Treatment of inherited eye defects by systemic hematopoietic stem cell transplantation","volume":"56","author":"Rocca","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.yexmp.2025.104995_bb0510","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","article-title":"Unlocking the promise of mRNA therapeutics","volume":"40","author":"Rohner","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0515","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.exphem.2023.07.006","article-title":"Expanding hematopoietic stem cell ex vivo: recent advances and technical considerations","volume":"125","author":"Rubio-Lara","year":"2023","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0520","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archinte.1970.00310040084009","article-title":"Intracellular cystine content of leukocyte populations in cystinosis","volume":"125","author":"Schulman","year":"1970","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.yexmp.2025.104995_bb0525","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/jimd.12164","article-title":"Central nervous system complications in adult cystinosis patients","volume":"43","author":"Servais","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.yexmp.2025.104995_bb0530","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2741\/2714","article-title":"The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy","volume":"13","author":"Shacka","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.yexmp.2025.104995_bb0535","first-page":"308","article-title":"The first molecular genetics analysis of individuals suffering from nephropatic cystinosis in the southwestern Iran","volume":"33","author":"Shahkarami","year":"2013","journal-title":"Nefrologia"},{"key":"10.1016\/j.yexmp.2025.104995_bb0540","first-page":"206","article-title":"Targeted therapy of kidney disease with nanoparticle drug delivery materials","volume":"37","author":"Shang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.yexmp.2025.104995_bb0545","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jconrel.2024.03.056","article-title":"mRNA therapies: pioneering a new era in rare genetic disease treatment","volume":"369","author":"Shen","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.yexmp.2025.104995_bb0550","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1086\/302118","article-title":"CTNS mutations in an American-based population of cystinosis patients","volume":"63","author":"Shotelersuk","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yexmp.2025.104995_bb0555","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jpeds.2016.12.050","article-title":"Pulmonary complications of cystinosis","volume":"183","author":"Simon","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.yexmp.2025.104995_bb0560","first-page":"2542","article-title":"Successful treatment of the murine model of cystinosis using bone marrow cell transplantation","volume":"114","author":"Syres","year":"2009","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0565","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00467-010-1502-5","article-title":"Analysis of CTNS gene transcripts in nephropathic cystinosis","volume":"25","author":"Taranta","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0570","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.bbrc.2012.08.115","article-title":"Activation of AMP kinase plays a role in the increased apoptosis in the renal proximal tubule in cystinosis","volume":"426","author":"Taub","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexmp.2025.104995_bb0575","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1001\/jama.1993.03510180070036","article-title":"Classic nephropathic cystinosis as an adult disease","volume":"270","author":"Theodoropoulos","year":"1993","journal-title":"Jama"},{"key":"10.1016\/j.yexmp.2025.104995_bb0580","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1172\/JCI108448","article-title":"Intracellular cystine depletion by aminothiols in vitro and in vivo","volume":"58","author":"Thoene","year":"1976","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2025.104995_bb0585","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00467-020-04638-9","article-title":"Nephropathic cystinosis: an update on genetic conditioning","volume":"36","author":"Topaloglu","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0590","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00467-011-1942-6","article-title":"Genetic basis of cystinosis in Turkish patients: a single-center experience","volume":"27","author":"Topaloglu","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0595","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2215\/CJN.00180117","article-title":"The clinical and mutational spectrum of Turkish patients with cystinosis","volume":"12","author":"Topaloglu","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0600","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ng0498-319","article-title":"A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis","volume":"18","author":"Town","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexmp.2025.104995_bb0605","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jpeds.2016.12.054","article-title":"Neurocognitive complications of cystinosis","volume":"183","author":"Trauner","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.yexmp.2025.104995_bb0610","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.survophthal.2006.10.006","article-title":"Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature","volume":"52","author":"Tsilou","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-021-01991-2","article-title":"A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis","volume":"16","author":"van Stein","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexmp.2025.104995_bb0620","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jimd.12562","article-title":"Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: a multicenter sibling cohort study","volume":"46","author":"Veys","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.yexmp.2025.104995_bb0625","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1021\/acs.accounts.1c00550","article-title":"Lipid nanoparticle\u2013mRNA formulations for therapeutic applications","volume":"54","author":"Wang","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.yexmp.2025.104995_bb0630","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00439-006-0165-6","article-title":"Treatment of human disease by adeno-associated viral gene transfer","volume":"119","author":"Warrington","year":"2006","journal-title":"Hum. Genet."},{"key":"10.1016\/j.yexmp.2025.104995_bb0635","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuropharm.2012.03.004","article-title":"Adeno-associated virus (AAV) gene therapy for neurological disease","volume":"69","author":"Weinberg","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yexmp.2025.104995_bb0640","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00467-010-1627-6","article-title":"Cystinosis: practical tools for diagnosis and treatment","volume":"26","author":"Wilmer","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2025.104995_bb0645","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/ki.2010.537","article-title":"Kidney preservation by bone marrow cell transplantation in hereditary nephropathy","volume":"79","author":"Yeagy","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexmp.2025.104995_bb0650","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0005-2736(00)00389-8","article-title":"Homologues of archaeal rhodopsins in plants, animals and fungi: structural and functional predications for a putative fungal chaperone protein","volume":"1511","author":"Zhai","year":"2001","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.yexmp.2025.104995_bb0655","doi-asserted-by":"crossref","first-page":"10328","DOI":"10.1074\/jbc.M116.764076","article-title":"Cystinosin, the small GTPase Rab11, and the Rab7 effector RILP regulate intracellular trafficking of the chaperone-mediated autophagy receptor LAMP2A","volume":"292","author":"Zhang","year":"2017","journal-title":"J. Biol. Chem."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:35:42Z","timestamp":1782952542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480025000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":131,"alternative-id":["S0014480025000450"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.104995","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic strategies in cystinosis: A focus on cysteamine and beyond","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.104995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104995"}}